BioRestorative Therapies, Inc.
Market Cap
$2.10M
P/E Ratio
-0.15
EPS
$-1.58
Dividend Yield
0.00%
52-Week Range
$0.19 — $2.04
Volume
795.15K
Avg Volume
9.70M
Beta
0.27
Get alerted when BRTX hits your target price.
Free — enter your email to get started
P/E (TTM)
-0.15
Forward P/E
—
PEG Ratio
0.02
P/S (TTM)
6.42
P/B (TTM)
6.39
P/FCF
—
EV/EBITDA
—
EV/Sales
—
ROE (TTM)
-4.20%
ROA (TTM)
-3.49%
ROIC
—
Gross Margin
0.64%
Operating Margin
-43.50%
Net Margin
—
Debt/Equity
0.00
Current Ratio
0.84
EPS Growth (YoY)
—
Revenue Growth (YoY)
—
EPS Growth (3Y)
+0.59%
EPS Growth (5Y)
+0.49%
Sales Growth (3Y)
+1.19%
Sales Growth (5Y)
+0.55%
EPS Est (This Year)
$-0.49
EPS Est (Next Year)
$-0.41
Dividend Yield
—
Annual Dividend
—
Payout Ratio
—
Frequency
—
Ex-Dividend Date
—
Cash/Share
$0.33
Institutional %
—
Inst. Net Change
—
Insider Net Shares (90d)
—
Outstanding Shares
8.99M
Float
5.98M
Free Float %
66.46%
Sector
Healthcare
Industry
Biotechnology
Country
US
Exchange
NASDAQ
IPO Date
2012-12-05
Employees
11
CEO
Lance Alstodt
Index Membership
—
Website
https://www.biorestorative.com
BioRestorative Therapies, Inc. (BRTX) is a healthcare company in the biotechnology industry listed on the NASDAQ. With a market capitalization of $2.10M, a P/E ratio of -0.15, BRTX is tracked by stockscreenr alongside 25,000+ other tickers. Use the free stock screener to compare BRTX against other stocks using dozens of fundamental and technical filters.
BioRestorative Therapies, Inc. (BRTX) has a trailing twelve-month (TTM) P/E ratio of -0.15. This is below the market average, which may suggest the stock is undervalued or has lower growth expectations. The P/E ratio measures how much investors are willing to pay per dollar of earnings.
No, BioRestorative Therapies, Inc. (BRTX) does not currently pay a regular dividend. The company may be reinvesting profits into growth, research, or debt reduction instead of returning cash to shareholders through dividends.
BioRestorative Therapies, Inc. (BRTX) has a market capitalization of $2.10 million, classifying it as a micro-cap company. Market cap is calculated by multiplying the current share price by the total number of outstanding shares.